首页> 美国卫生研究院文献>iScience >The revival of dithiocarbamates: from pesticides to innovative medical treatments
【2h】

The revival of dithiocarbamates: from pesticides to innovative medical treatments

机译:二硫代氨基酯的复兴:从农药到创新的医疗治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dithiocarbamates (DTCs) have been used for various applications, including as hardening agents in rubber manufacturing, as fungicide in agriculture, and as medications to treat alcohol misuse disorder. The multi-faceted effects of DTCs rely mainly on metal binding abilities and a high reactivity with thiol groups. Therefore, the list of potential applications is still increasing, exemplified by the US Food and Drug Administration approval of disulfiram (Antabuse) and its metabolite diethyldithiocarbamate in clinical trials against cancer, human immunodeficiency virus, and Lyme disease, as well as new DTC-related compounds that have been synthesized to target diseases with unmet therapeutic needs. In this review, we will discuss the latest progress of DTCs as anti-cancer agents and provide a summary of the mechanisms of action. We will explain the expansion of DTCs' activity in the fields of microbiology, neurology, cardiology, and ophthalmology, thereby providing evidence for the important role and therapeutic potential of DTCs as innovative medical treatments.
机译:二硫代氨基甲酰胺(DTC)已用于各种应用,包括橡胶制造中的硬化剂,作为农业的杀真菌剂,以及治疗酒精滥用疾病的药物。 DTCs的多刻度效应主要依赖于金属结合能力和与硫醇基的高反应性。因此,潜在的应用名单仍然增加,通过美国食品和药物管理局批准二硫仑(坦布)及其代谢产物二乙基硫代氨基甲酸酯对抗癌症,人类免疫缺陷病毒和莱姆病的临床试验以及新的DTC相关已经合成给靶向疾病的化合物,具有未满足的治疗性需求。在本综述中,我们将讨论DTCS作为抗癌代理的最新进展,并提供行动机制的摘要。我们将解释在微生物学,神经学,心脏病学和眼科领域的DTCS活动的扩展,从而为DTCS作为创新的医疗治疗的重要作用和治疗潜力提供了证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号